tiprankstipranks
I-MAB (IMAB)
NASDAQ:IMAB
US Market

I-MAB (IMAB) Similar Stocks

Compare
298 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
I-MAB
$0.84
$64.80M
-54.29%
2 Buy
0 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$0.85
$101.03M
-87.62%
4 Buy
8 Hold
0 Sell
Moderate Buy
Affimed
$0.78
$12.26M
-85.26%
1 Buy
0 Hold
0 Sell
Moderate Buy
BeiGene
$267.39
$30.00B
73.84%
11 Buy
1 Hold
0 Sell
Strong Buy
Zai Lab
$37.29
$3.90B
132.77%
4 Buy
1 Hold
0 Sell
Strong Buy
Genmab
$19.90
$12.12B
11.09
-35.45%
4 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMAB
I-MAB
0.84
-0.97
-53.59%
FATE
Fate Therapeutics
0.85
-6.23
-87.99%
AFMD
Affimed
0.78
-5.57
-87.72%
ONC
BeiGene
267.39
108.16
67.93%
ZLAB
Zai Lab
37.29
20.57
123.03%
GMAB
Genmab
19.90
-10.37
-34.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis